1 |
Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease[J]. Trends PharmacolSci, 2009, 30(5):260-267.
|
2 |
周春辉,王晓晴,张剑宁. 干细胞移植治疗帕金森病的研究进展[J]. 转化医学杂志, 2013, 2(6):341-343,347
|
3 |
Barker RA, Barrett J, Mason SL, et al. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease[J]. Lancet Neurol, 2013, 12(1):84-91.
|
4 |
Han FB, Wang W, Chen BX, et al. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease[J]. Cytotherapy, 2015, 17(5):665-679.
|
5 |
Hargus G, Cooper O, Deleidi M, et al. Differentiated parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats[J]. Proc Natl Acad Sci U S A, 2010, 107(36):15921-15926.
|
6 |
Venkataramana NK, Kumar SK, Balaraju S, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease[J]. Transl Res, 2010, 155(2):62-70.
|
7 |
Blandini F, Cova L, Armentero M, et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-Hydroxydopamine neurotoxicity in the rat[J]. Cell Transplant, 2010, 19(2):203-217.
|
8 |
Hows JM, Marsh JC, Bradley BA, et al. Human cord blood: a source of transplantable stem cells[J]. Bone Marrow Transplant, 1992, 9(1):105-108.
|
9 |
Yang WZ, Zhang Y, Wu F, et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions[J]. J Transl Med, 2010, 8:75.
|
10 |
Weiss ML, Troyer DL. Stem cells in the umbilical cord[J]. Stem Cell Rev, 2006, 2(2):155-162.
|
11 |
Karlupia N, Manley NC, Prasad K, et al. Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model[J]. Stem Cell Res Ther, 2014, 5(2):45.
|
12 |
Rodrigues LP, Iglesias D, Nicola FC, et al. Transplantation of mononuclear cells from human umbilical cord blood promotes functional recovery after traumatic spinal cord injury in Wistarrats[J]. Braz J Med Biol Res, 2012, 45(1):49-57.
|
13 |
Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats[J]. Stroke, 2001, 32(11):2682-2688.
|
14 |
Domanska-Janik K BL, Lukomska B. A novel, neural potential of non-hematopoietic human umbilical cord blood stem cells[J]. Int J DevBiol, 2008, 52(2/3):237-248.
|
15 |
Zangiacomi V, Balon N, Maddens S, et al. Human cord blood-derived hematopoietic and neural-like stem/progenitor cells are attracted by the neurotransmitter GABA[J]. Stem Cells Dev, 2009, 18(9):1369-1378.
|
16 |
Suzuki M, Mchugh J, Tork C, et al. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS[J]. PLoS One, 2007, 2(8):e689.
|
17 |
Li H, Li J, Sheng WH, et al. Astrocyte-like cells differentiated from a novel population of CD45-positive cells in adult human peripheral blood[J]. Cell BiolInt, 2015, 39(1):84-93.
|
18 |
Mcguckin CP, Forraz N, Allouard Q, et al. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro[J]. Exp Cell Res, 2004, 295(2):350-359.
|
19 |
Chen N, Kamath S, Newcomb J, et al. Trophic factor induction of human umbilical cord blood cells in vitro and in vivo[J]. J Neural Eng, 2007, 4(2):130-145.
|
20 |
Newcomb JD, Ajmo CT, Sanberg CD, et al. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy[J]. Cell Transplant, 2006, 15(3):213-223.
|
21 |
宫殿荣,于海燕,赵敏, 等. 寰枕间隙侧方穿刺移植脐血单个核细胞治疗多系统萎缩的临床观察[J]. 中华细胞与干细胞杂志(电子版), 2016, 4(6):115-120.
|
22 |
Saporta S, Kim JJ, Willing AE, et al. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior[J]. J Hematother Stem Cell Res, 2003, 12(3):271-278.
|